Published in Curr Opin Pulm Med on May 01, 2009
HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev (2011) 3.28
Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis (2011) 2.59
Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev (2014) 2.43
Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One (2009) 2.34
Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One (2010) 2.03
Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence. Pulm Med (2013) 1.98
Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr (2011) 1.95
Central nervous system tuberculosis. Afr Health Sci (2011) 1.83
Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis (2012) 1.57
The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One (2011) 1.42
Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One (2010) 1.34
Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. Am J Respir Crit Care Med (2012) 1.30
Evaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populations. Clin Vaccine Immunol (2010) 1.22
Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden. PLoS One (2011) 1.19
Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar. Clin Vaccine Immunol (2010) 1.17
Malnutrition and helminth infection affect performance of an interferon gamma-release assay. Pediatrics (2010) 1.17
Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa. PLoS One (2011) 1.15
IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect Dis (2011) 1.12
Systematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update. BMC Infect Dis (2014) 1.08
Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am J Respir Crit Care Med (2010) 1.08
Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect Dis (2010) 1.07
Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. Biotechnol Adv (2013) 1.06
Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection. Am J Respir Crit Care Med (2010) 1.03
Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases. PLoS One (2010) 1.00
Biosensors for immune cell analysis-A perspective. Biomicrofluidics (2012) 0.99
Monitoring CD27 expression to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo. PLoS One (2011) 0.98
Analysis of factors lowering sensitivity of interferon-γ release assay for tuberculosis. PLoS One (2011) 0.96
The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes. Int J Tuberc Lung Dis (2011) 0.95
High annual risk of tuberculosis infection among nursing students in South India: a cohort study. PLoS One (2011) 0.94
Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas? PLoS One (2011) 0.94
Quantiferon-Leishmania as an epidemiological tool for evaluating the exposure to Leishmania infection. Am J Trop Med Hyg (2010) 0.94
Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area. PLoS One (2012) 0.94
Reconfigurable microfluidics combined with antibody microarrays for enhanced detection of T-cell secreted cytokines. Biomicrofluidics (2013) 0.93
Performance of QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of Mycobacterium tuberculosis (Mtb) infection in Afar Pastoralists, Ethiopia. BMC Infect Dis (2010) 0.93
Challenges in endobronchial tuberculosis: from diagnosis to management. Pulm Med (2014) 0.89
Promise versus reality: optimism bias in package inserts for tuberculosis diagnostics. J Clin Microbiol (2012) 0.88
Prevalence of latent and active tuberculosis among dairy farm workers exposed to cattle infected by Mycobacterium bovis. PLoS Negl Trop Dis (2013) 0.87
Performance of interferon-γ release assays in the diagnosis of confirmed active tuberculosis in immunocompetent children: a new systematic review and meta-analysis. BMC Infect Dis (2016) 0.84
Diagnostics for Developing Countries. Diagnostics (Basel) (2015) 0.83
Rapid identification of the Mycobacterium tuberculosis complex by combining the ESAT-6/CFP-10 immunochromatographic assay and smear morphology. J Clin Microbiol (2010) 0.83
Accuracy of the QuantiFERON-TB Gold in Tube for diagnosing tuberculosis in a young pediatric population previously vaccinated with Bacille Calmette-Guérin . Rev Paul Pediatr (2014) 0.82
Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects. Diagn Microbiol Infect Dis (2011) 0.82
Implications of the impact of prevalence on test thresholds and outcomes: lessons from tuberculosis. BMC Res Notes (2012) 0.81
Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil. PLoS One (2014) 0.81
Monitoring of peptide-specific and gamma interferon-productive T cells in patients with active and convalescent tuberculosis using an enzyme-linked immunosorbent spot assay. Clin Vaccine Immunol (2012) 0.81
Stratified Threshold Values of QuantiFERON Assay for Diagnosing Tuberculosis Infection in Immunocompromised Populations. Tuberc Res Treat (2011) 0.80
Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma. Cells (2012) 0.79
Comparative evaluation of MPT83 (Rv2873) for T helper-1 cell reactivity and identification of HLA-promiscuous peptides in Mycobacterium bovis BCG-vaccinated healthy subjects. Clin Vaccine Immunol (2011) 0.79
Mycobacterium tuberculosis infection in young children: analyzing the performance of the diagnostic tests. PLoS One (2014) 0.79
Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in europe. PLoS One (2014) 0.78
Characterization of a cross-reactive, immunodominant and HLA-promiscuous epitope of Mycobacterium tuberculosis-specific major antigenic protein PPE68. PLoS One (2014) 0.78
Comparison of mantoux and tine tuberculin skin tests in BCG-vaccinated children investigated for tuberculosis. PLoS One (2009) 0.78
Diagnostic values of the QuantiFERON-TB Gold In-tube assay carried out in China for diagnosing pulmonary tuberculosis. PLoS One (2015) 0.78
Epidemiology and clinical management of tuberculosis in children in Canada. Paediatr Child Health (2015) 0.76
Tuberculin skin test and ELISPOT/T. SPOT.TB in children and adolescents with juvenile idiopathic arthritis. Pediatr Rheumatol Online J (2014) 0.75
Should interferon gamma release assays become the standard method for screening patients for Mycobacterium tuberculosis infections in the United States? J Clin Microbiol (2011) 0.75
Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts. BMC Infect Dis (2014) 0.75
Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis. BMC Infect Dis (2017) 0.75
Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm). BMC Infect Dis (2016) 0.75
Tracheobronchial tuberculosis. J Thorac Dis (2016) 0.75
Negative Mantoux test in a patient with definite pulmonary and ocular tuberculosis. Taiwan J Ophthalmol (2014) 0.75
Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis (2006) 9.35
Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med (2007) 8.81
Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS (2005) 6.83
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev (2013) 5.78
Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS (2003) 5.52
Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis (2011) 5.34
Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med (2011) 5.25
Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med (2007) 5.20
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev (2014) 5.14
Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med (2006) 4.96
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet (2010) 4.95
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet (2010) 4.71
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
International standards for tuberculosis care. Lancet Infect Dis (2006) 4.67
Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis (2006) 4.63
Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis (2008) 4.14
Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis (2010) 3.83
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr (2006) 3.39
Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med (2012) 3.26
Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS One (2008) 3.07
Xpert MTB/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact. Clin Infect Dis (2014) 3.07
A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis (2005) 3.05
Tuberculosis diagnosis--time for a game change. N Engl J Med (2010) 2.96
Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med (2012) 2.84
Bridging the gap between knowledge and health: the epidemiologist as Accountable Health Advocate ("AHA!"). Epidemiology (2012) 2.74
Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med (2007) 2.71
Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev Anti Infect Ther (2007) 2.62
Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax (2011) 2.61
Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect (2006) 2.59
Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis (2011) 2.59
Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med (2009) 2.55
Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med (2008) 2.52
The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med (2007) 2.39
Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One (2009) 2.34
Tuberculosis control: business models for the private sector. Lancet Infect Dis (2012) 2.32
In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression. BMC Microbiol (2005) 2.24
Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis. PLoS Med (2011) 2.24
Risk factors for acute myocardial infarction in a rural population of central India: a hospital-based case-control study. Natl Med J India (2004) 2.23
High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers. Ann Intern Med (2010) 2.23
Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med (2011) 2.14
Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One (2010) 2.03
Systematic reviews of diagnostic test evaluations: What's behind the scenes? ACP J Club (2004) 2.02
Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med (2011) 2.02
Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India. PLoS Med (2008) 1.96
The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med (2011) 1.95
Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr (2011) 1.95
Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med (2009) 1.95
Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India. PLoS One (2007) 1.94
Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc (2006) 1.94
T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One (2008) 1.91
Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin Vaccine Immunol (2008) 1.80
Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother (2009) 1.75
Light-emitting diode technologies for TB diagnosis: what is on the market? Expert Rev Med Devices (2009) 1.70
Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review. Ann Am Thorac Soc (2014) 1.70
Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs. Discov Med (2012) 1.66
Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. Clin Infect Dis (2010) 1.66
Why are inaccurate tuberculosis serological tests widely used in the Indian private healthcare sector? A root-cause analysis. J Epidemiol Glob Health (2012) 1.66
Recent advances in the diagnosis of childhood tuberculosis. Arch Dis Child (2007) 1.65
Accuracy and reliability of palpation and percussion for detecting hepatomegaly: a rural hospital-based study. Indian J Gastroenterol (2004) 1.62
Which new diagnostics for tuberculosis, and when? J Infect Dis (2012) 1.58
Can social interventions prevent tuberculosis?: the Papworth experiment (1918-1943) revisited. Am J Respir Crit Care Med (2012) 1.55
Effect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients. J Acquir Immune Defic Syndr (2011) 1.52
Tuberculosis diagnostics trials: do they lack methodological rigor? Expert Rev Mol Diagn (2006) 1.51
HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Muscle Nerve (2010) 1.51
New approaches and emerging technologies in the diagnosis of childhood tuberculosis. Paediatr Respir Rev (2007) 1.47
TB diagnostic tests: how do we figure out their costs? Expert Rev Anti Infect Ther (2009) 1.47
Tuberculosis control in India: time to get dangerously ambitious? Natl Med J India (2011) 1.44
Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topic. Cardiovasc J Afr (2013) 1.41
Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Current standards and challenges. Can J Infect Dis Med Microbiol (2008) 1.40
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. Lancet Infect Dis (2013) 1.39
Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis (2006) 1.39
Protecting healthcare workers from tuberculosis in the era of extensively drug-resistant tuberculosis. Natl Med J India (2007) 1.38
Quality and reporting of diagnostic accuracy studies in TB, HIV and malaria: evaluation using QUADAS and STARD standards. PLoS One (2009) 1.37
A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Thorax (2007) 1.35
Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One (2009) 1.34
Spectrum of latent tuberculosis - existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol (2010) 1.32
Discordance between tuberculin skin test and interferon-gamma assays. Int J Tuberc Lung Dis (2006) 1.32
Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis (2007) 1.31
Frequency and clinical genetics of familial dilated cardiomyopathy in Cape Town: implications for the evaluation of patients with unexplained cardiomyopathy. S Afr Med J (2011) 1.27
Nutritional status of adult patients with pulmonary tuberculosis in rural central India and its association with mortality. PLoS One (2013) 1.26
Rapid diagnosis of drug-resistant TB using line probe assays: from evidence to policy. Expert Rev Respir Med (2008) 1.25
Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med (2010) 1.23
Priorities for tuberculosis research: a systematic review. Lancet Infect Dis (2010) 1.22
Tuberculosis infection among young nursing trainees in South India. PLoS One (2010) 1.21
Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa. Heart Rhythm (2009) 1.20
Interferon-gamma assays for tuberculosis: is anergy the Achilles' heel? Am J Respir Crit Care Med (2005) 1.20
Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum (2004) 1.20
Clinical characteristics and outcomes of familial and idiopathic dilated cardiomyopathy in Cape Town: a comparative study of 120 cases followed up over 14 years. S Afr Med J (2011) 1.20
Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population. PLoS One (2011) 1.19
International Standards for Tuberculosis Care: revisiting the cornerstones of tuberculosis care and control. Expert Rev Anti Infect Ther (2007) 1.18
Stroke outcomes in a socio-economically disadvantaged urban community. S Afr Med J (2011) 1.16
Rapid diagnosis of extrapulmonary tuberculosis using nucleic acid amplification tests: what is the evidence? Future Microbiol (2008) 1.15
The new IGRA and the old TST: making good use of disagreement. Am J Respir Crit Care Med (2007) 1.12
Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa. PLoS One (2013) 1.12
Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med (2013) 1.11